Targeted News Service

HER2-Targeted Radioimmunotherapy Regimen Achieves Complete and Durable Response in Breast Cancer
November 03, 2025

RESTON, Virginia, Nov. 3 [Category: Medical] -- The Society of Nuclear Medicine and Molecular Imaging issued the following news release:

* * *

HER2-Targeted Radioimmunotherapy Regimen Achieves Complete and Durable Response in Breast Cancer

*

Media Contact:

Rebecca Maxey

(703) 652-6772

rmaxey@snmmi.org

Model

Reston, VA (November 3, 2025) A new radioimmunotherapy approach has . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form